14-23431868-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_Strong
The NM_000257.4(MYH7):c.532G>A(p.Gly178Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000257.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.532G>A | p.Gly178Arg | missense_variant, splice_region_variant | 7/40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.532G>A | p.Gly178Arg | missense_variant, splice_region_variant | 6/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.532G>A | p.Gly178Arg | missense_variant, splice_region_variant | 7/40 | 1 | NM_000257.4 | ENSP00000347507.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251472Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135912
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461774Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727202
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | research | Agnes Ginges Centre for Molecular Cardiology, Centenary Institute | Mar 16, 2017 | The MYH7 Gly178Arg has previously been identified in 1 HCM patient (Waldmuller S et al., 2011), 1 LVNC patient (Blueprint Genetics, ClinVar SCV000207087.1) and in at least 3 DCM patients (Genedx, ClinVar SCV000208677.6; Walsh R, et al., 2017). The variant is absent from both the 1000 genomes project (http://www.1000genomes.org/) and the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/). We have identified the MYH7 Gly178Arg variant in a LVNC patient with a family history of disease (3 other affected members; genetic segregation not possible). Computational tools SIFT, MutationTaster, and PolyPhen-2 predict this variant to have a deleterious effect. Additionally PolyPhen-HCM, a tool specifically designed to predict the effects of missense variants in HCM genes (Jordan DM, et al., 2011), predicts this variant to cause disease. In summary, although MYH7 Gly178Arg is absent in the general population and in silico tools support a pathogenic role, further evidence is required to understand its role in LVNC and cardiomyopathy. Hence, we classify MYH7 Gly178Arg as a variant of "uncertain significance". - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 178 of the MYH7 protein (p.Gly178Arg). This variant is present in population databases (rs730880156, gnomAD 0.004%). This missense change has been observed in individuals with clinical features of left ventricular noncompaction, dilated cardiomyopathy, and/or hypertrophic cardiomyopathy (PMID: 21750094, 27532257; Invitae). ClinVar contains an entry for this variant (Variation ID: 180432). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jan 07, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2023 | Located in a region enriched with missense variants reported in association with HCM (PMID: 27532257, 29300372); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 21750094, 27532257, 29300372, 36243179, 35113650) - |
Left ventricular noncompaction cardiomyopathy Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Blueprint Genetics | Dec 01, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at